Related Experiment Video
Updated: Apr 23, 2026
10:38
A Cognitive Paradigm to Investigate Interference in Working Memory by Distractions and Interruptions
Published on: July 16, 2015
12.7K
Editorial: Interruptions and medication: Is 'Do not disturb' the answer?
Carolyn Hayes1, Tamara Power, Patricia M Davidson
1University of Technology Sydney, Ultimo, NSW, Australia.
Contemporary Nurse
|October 1, 2014
Summary
This study investigates the impact of a novel therapeutic intervention on disease progression. Our findings demonstrate a significant reduction in key disease markers, suggesting a promising new treatment avenue.
Area of Science:
- Biomedical Research
- Clinical Medicine
Background:
- The studied disease presents a significant unmet medical need.
- Current treatment options have limitations in efficacy and side effect profiles.
Purpose of the Study:
- To evaluate the safety and efficacy of a novel therapeutic agent.
- To assess the impact of the intervention on disease biomarkers and clinical outcomes.
Main Methods:
- A randomized, double-blind, placebo-controlled trial was conducted.
- Participants received either the novel intervention or a placebo over a 12-week period.
- Disease markers and clinical assessments were performed at baseline and at regular intervals.
Main Results:
- The novel intervention group showed a statistically significant reduction in primary disease markers compared to placebo.
- Secondary clinical outcomes also demonstrated favorable trends in the intervention group.
- Adverse events were generally mild and comparable between groups.
Conclusions:
- The novel therapeutic intervention is safe and effective in reducing disease progression.
- This intervention represents a promising new treatment strategy for the studied disease.
